Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing irbesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely irbesartan 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Irbesartan 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide+irbesartan 12.5mg/150mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydrochlorothiazide and irbesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Adverse reaction caused by irbesartan (disorder) |
Causative agent (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely irbesartan 75 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely irbesartan 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan 300 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan hydrochloride (substance) |
Is a |
False |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely irbesartan 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide 12.5 mg and irbesartan 150 mg oral tablet |
Has precise active ingredient |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan 150 mg oral tablet |
Has precise active ingredient |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan 300 mg oral tablet |
Has precise active ingredient |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing irbesartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only irbesartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydrochlorothiazide and irbesartan only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only irbesartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Irbesartan hydrochloride (substance) |
Is modification of (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydrochlorothiazide 12.5 mg and irbesartan (as irbesartan hydrochloride) 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan (as irbesartan hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydrochlorothiazide 25 milligram and irbesartan (as irbesartan hydrochloride) 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Irbesartan (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |